Mr. Rob Hill reports
EMERALD HEALTH THERAPEUTICS PROMOTES PAUL R. DILLMAN, JR. TO EXECUTIVE VICE PRESIDENT OF GLOBAL SALES AND MARKETING
Emerald Health Therapeutics Inc. has promoted Paul R. Dillman Jr. to executive vice-president of global sales and marketing. Mr. Dillman previously served as vice-president of sales and marketing, and will now be responsible for leading international marketing, sales and customer services for Emerald as the company prepares to participate in the new legal cannabis landscape.
"Paul has been instrumental in preparing the Emerald brand for adult-use legalization in Canada," said Chris Wagner, chief executive officer of Emerald. "With our branding, marketing and sales strategy, Emerald is poised to be a premiere provider of cannabis for medical and adult-use consumers. Paul's marketing expertise has been invaluable to our team over the past few months, and we look forward to positioning Emerald to be a leader in Canada as well as the global cannabis industry."
Mr. Dillman has three decades of experience in global marketing, sales and general management, and prior to Emerald he held senior leadership positions at The Coca-Cola Company, AB InBev, Philip Morris and Kraft Foods. Mr. Dillman earned a bachelor of science from West Point (United States Military Academy) and a master of science in systems management from the University of Southern California.
The company has granted 50,000 stock options to Mr. Dillman to purchase up to an aggregate of 50,000 common shares of the company at an exercise price of $4.60 per option share, vesting over a period of three years and exercisable for five years from the date of grant.
About Emerald Health Therapeutics Inc.
Emerald Health Therapeutics is a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50 per cent of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, B.C., and is in commercial production. It owns Agro-Biotech, a Quebec-based licensed cannabis grower with a 75,000-square-foot indoor facility. Emerald has also entered into hemp chaff purchase agreements in 2018 and subsequent years. Emerald's team is highly experienced in life sciences, product development, large-scale agribusiness and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.